Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis.

Qiu C, Wang Y, Zhao H, Qin L, Shi Y, Zhu X, Song L, Zhou X, Chen J, Zhou H, Zhang H, Tellides G, Min W, Yu L.

Nat Commun. 2017 Jun 1;8:15426. doi: 10.1038/ncomms15426.

2.

Compositional Control of Phase-Separated Cellular Bodies.

Banani SF, Rice AM, Peeples WB, Lin Y, Jain S, Parker R, Rosen MK.

Cell. 2016 Jul 28;166(3):651-63. doi: 10.1016/j.cell.2016.06.010. Epub 2016 Jun 30.

PMID:
27374333
3.

Sumoylation and transcription regulation at nuclear pores.

Texari L, Stutz F.

Chromosoma. 2015 Mar;124(1):45-56. doi: 10.1007/s00412-014-0481-x. Epub 2014 Aug 30. Review.

4.

Transcriptional repression of estrogen receptor ╬▒ signaling by SENP2 in breast cancer cells.

Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, Cavaill├Ęs V, Jalaguier S.

Mol Endocrinol. 2014 Feb;28(2):183-96. doi: 10.1210/me.2013-1376. Epub 2013 Jan 1.

5.

Sumoylation at the host-pathogen interface.

Wilson VG.

Biomolecules. 2012 Apr 5;2(2):203-27. doi: 10.3390/biom2020203.

6.

SUMO regulates proteasome-dependent degradation of FLASH/Casp8AP2.

Vennemann A, Hofmann TG.

Cell Cycle. 2013 Jun 15;12(12):1914-21. doi: 10.4161/cc.24943. Epub 2013 May 13.

7.

Post-translational modifications of PML: consequences and implications.

Cheng X, Kao HY.

Front Oncol. 2013 Jan 4;2:210. doi: 10.3389/fonc.2012.00210. eCollection 2012.

8.

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Maroui MA, Kheddache-Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi-Alix MK.

PLoS One. 2012;7(9):e44949. doi: 10.1371/journal.pone.0044949. Epub 2012 Sep 18.

9.

Lens epithelium-derived growth factor deSumoylation by Sumo-specific protease-1 regulates its transcriptional activation of small heat shock protein and the cellular response.

Ishihara K, Fatma N, Bhargavan B, Chhunchha B, Kubo E, Dey S, Takamura Y, Kumar A, Singh DP.

FEBS J. 2012 Sep;279(17):3048-70. doi: 10.1111/j.1742-4658.2012.08686.x. Epub 2012 Jul 16.

10.

DeSUMOylating isopeptidase: a second class of SUMO protease.

Shin EJ, Shin HM, Nam E, Kim WS, Kim JH, Oh BH, Yun Y.

EMBO Rep. 2012 Apr;13(4):339-46. doi: 10.1038/embor.2012.3.

11.

The SUMO-specific isopeptidase SENP2 associates dynamically with nuclear pore complexes through interactions with karyopherins and the Nup107-160 nucleoporin subcomplex.

Goeres J, Chan PK, Mukhopadhyay D, Zhang H, Raught B, Matunis MJ.

Mol Biol Cell. 2011 Dec;22(24):4868-82. doi: 10.1091/mbc.E10-12-0953. Epub 2011 Oct 26.

12.

The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.

Hattersley N, Shen L, Jaffray EG, Hay RT.

Mol Biol Cell. 2011 Jan 1;22(1):78-90. doi: 10.1091/mbc.E10-06-0504. Epub 2010 Dec 9.

13.

Distribution and paralogue specificity of mammalian deSUMOylating enzymes.

Kolli N, Mikolajczyk J, Drag M, Mukhopadhyay D, Moffatt N, Dasso M, Salvesen G, Wilkinson KD.

Biochem J. 2010 Sep 1;430(2):335-44. doi: 10.1042/BJ20100504.

14.

SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.

Yu L, Ji W, Zhang H, Renda MJ, He Y, Lin S, Cheng EC, Chen H, Krause DS, Min W.

J Exp Med. 2010 Jun 7;207(6):1183-95. doi: 10.1084/jem.20092215. Epub 2010 May 10.

15.

SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.

Kang X, Qi Y, Zuo Y, Wang Q, Zou Y, Schwartz RJ, Cheng J, Yeh ET.

Mol Cell. 2010 Apr 23;38(2):191-201. doi: 10.1016/j.molcel.2010.03.005.

16.

SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.

Witty J, Aguilar-Martinez E, Sharrocks AD.

Biochem J. 2010 May 13;428(2):247-54. doi: 10.1042/BJ20091948.

17.

Control of adipogenesis by the SUMO-specific protease SENP2.

Chung SS, Ahn BY, Kim M, Choi HH, Park HS, Kang S, Park SG, Kim YB, Cho YM, Lee HK, Chung CH, Park KS.

Mol Cell Biol. 2010 May;30(9):2135-46. doi: 10.1128/MCB.00852-09. Epub 2010 Mar 1.

18.

A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Van Damme E, Laukens K, Dang TH, Van Ostade X.

Int J Biol Sci. 2010 Jan 12;6(1):51-67. Review.

19.

The mRNA expression of SATB1 and SATB2 in human breast cancer.

Patani N, Jiang W, Mansel R, Newbold R, Mokbel K.

Cancer Cell Int. 2009 Jul 30;9:18. doi: 10.1186/1475-2867-9-18.

20.

Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity.

Chen X, Zhu F, Cao Y, Qiao S.

Antimicrob Agents Chemother. 2009 Sep;53(9):3683-9. doi: 10.1128/AAC.00251-09. Epub 2009 Jun 22.

Supplemental Content

Support Center